Toll-like receptor (TLR) 4/MD-2 dimerization is thought to be required for the initiation of signaling during innate immune responses. In this study, we examined the molecular mechanisms underlying receptor dimerization in the context of accessory molecules, i.e. CD14 and lipopolysaccharidebinding protein (LBP), to determine whether dimerization is required for the initiation of signaling in response to LPS stimulation. We found that LPS-induced TLR4/MD-2 dimerization occurred only in membrane-associated CD14 (mCD14)-expressing cells. Furthermore, dimerization required LBP, but not soluble CD14 (sCD14), as an essential serum component. LPS-induced signaling as assessed by IkB-a degradation, however, occurred in mCD14-negative cells in the presence of serum and sCD14. Signaling also occurred in mCD14-positive cells in the absence of serum. Time course studies on mCD14-positive cells have demonstrated that LPS stimulation induces rapid activation of nuclear factor-kappaB and p38 in the presence of LBP (TLR4/MD-2 receptor dimerization) as compared with stimulation without LBP (receptor non-dimerization). This early activation was blocked by inhibitory anti-CD14 mAb. These studies suggest that LPS-induced TLR4/MD-2 receptor dimerization is not essential for signaling but prompts rapid signaling during innate immune responses.
Introduction
Although adaptive immunity responds to specific antigens, innate immune responses recognize conserved structural patterns in foreign molecules of microorganisms known as pathogen-associated molecular patterns (PAMPs) (1) . Members of the Toll-like receptor (TLR) family play an essential role in the innate recognition of PAMPs (2) . TLR4 requires the presence of an association molecule, MD-2, for cell surface localization and signaling initiation induced by LPS, a Gram-negative bacterial cell surface component (3) . Secretory glycoprotein MD-2 forms a stable complex via association with the extracellular domain of TLR4 (4, 5) . Lipid A, a minimal immunostimulatory element of LPS, is composed of phosphorylated b(1,6)-linked D-glucosamine disaccharide with associated acylated lipid chains (6) . The pathogenicity of lipid A depends on its length, position and number of fatty acid chains (7) (8) (9) . MD-2 discriminates the fine structures of lipid A and thereby regulates the activation of TLR4 (7, 9, 10) .
The TLR4/MD-2 complex activates the signaling pathway via the recruitment of adapter proteins, such as MyD88 and Toll-IL-1R domain-containing adapter-inducing IFN-b (TRIF), to its intracellular Toll-IL-1R domain (2) .
In addition to TLR4 and MD-2, serum lipopolysaccharidebinding protein (LBP) and membrane-associated CD14 (mCD14), a glycerophosphatidylinositol-anchored macrophage/ monocyte surface protein, are important in LPS-induced innate immunity (11) . Cellular introduction of mCD14 leads to marked increases in LPS-binding capacity, which is further enhanced by LBP (12) ; however, inhibitory anti-mCD14 mAbs attenuate the activation of cells against LPS stimulation (12, 13) . In addition to the membrane-associated form, CD14 functions as a soluble form in serum (14, 15) . Similar to mCD14, soluble CD14 (sCD14) binds directly to LPS, which is promoted by LBP (16) (17) (18) . This interaction enables the activation of TLR4/MD-2 in mCD14-negative cells such as endothelial cells, smooth muscle cells and epithelial cells, which leads to up-regulated expression of adhesion molecules and increased secretion of humoral mediators (17, 19) . LBP binds to LPS via its N-terminal portion and transfers LPS to the soluble or membrane forms of CD14 via its C-terminal portion (16, 20) .
Some TLR members, including TLR4, function as dimers (21) (22) (23) (24) . The exchange of the TLR4 ectodomain with integrins provides constitutively active chimeric receptors by promoting dimerization (25) . Plates coated with anti-TLR4 or anti-MD-2 antibodies are capable of inducing nuclear factorkappaB (NF-jB) activation via receptor cross-linking (26) . The surface TLR4/MD-2 complex, which may be uniformly distributed on resting cells, rapidly forms a large cluster via oligomerization in response to LPS stimulation (26) (27) (28) (29) . Crystallographic structural analysis of soluble TLR4/MD-2 lacking a transmembrane domain has revealed that the dimer is formed in response to an agonist but not an antagonist (5, 30) . Furthermore, protein complementation assays using b-lactamase fragments have shown dimerization of TLR4 via a cytoplasmic interaction (31) . These studies strongly suggest that innate immune function activation through TLR4/MD-2 is mediated by ligand-induced receptor dimerization. Direct interactions of an agonistic ligand with the monomeric TLR4/MD-2 induce allosteric conformational changes and the subsequent formation of a homotypic dimer, which consists of two receptor complexes. The formation of this dimer results in the initiation of intracellular signaling (23, 24, 30) .
Immunobiological techniques have also been used to demonstrate ligand-induced TLR4 dimerization (32, 33) . In addition, the link between dimerization and signaling has been characterized using different LPS molecules with varying numbers of fatty acid chains. For example, hexaacylated LPS induces activation and dimerization of TLR4/ MD-2, whereas penta-acylated LPS, which is non-pathogenic in mice, fails to induce dimerization (9) . Lipid IVa, which lacks two of the fatty acid chains present in lipid A, is agonistic to mouse TLR4/MD-2 but antagonistic to the human complex (7, 33) . Consistent with species-specific pathogenicity, lipid IVa causes dimerization in mouse, but not human, TLR4/ MD-2 receptors (33). Therefore, TLR4/MD-2 dimerization may be essential for receptor activation (32, 33) .
In this study, we examined the molecular mechanisms underlying LPS-induced TLR4/MD-2 dimerization with respect to accessory molecules, i.e. CD14 and LBP, to determine the absolute requirements for receptor signaling. Using Ba/F3-transfectant cells, we found that LPS-induced dimerization occurs only in mCD14-expressing cells and requires LBP as an essential serum component. Unexpectedly, in the presence of whole serum or sCD14, mCD14-negative cells did not show dimerized receptors; however, NF-jB activation occurred upon stimulation by LPS. In addition, in the absence of whole serum or LBP, mCD14-positive cells showed NF-jB activation upon LPS stimulation without TLR4/MD-2 dimerization. Lastly, LPS-induced activation of signaling molecules occurred earlier with dimerization than without dimerization. Our results suggest that dimerization, which is not essential for TLR4/MD-2 activation in and of itself, enables the acceleration of downstream signaling.
Methods

Cells
Ba/F3 stable transfectants expressing mouse TLR4/MD-2 and mCD14 were gifts from Dr K. Miyake [Tokyo University, Tokyo, Japan; (34)] and were maintained in RPMI-1640 medium supplemented with 10% FCS, 100 U ml À1 mouse IL-3 and 50 lM 2-mercaptoethanol. Dihydrofolate reductasedeficient CHO-DG44 cells were provided by Dr H. Nakatake (Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan) and maintained in DMEM: Nutrient Mixture F-12 containing 10% FCS. The following cells were purchased from cell banks: mouse macrophage cell line RAW264 (RCB0535; Riken Cell Bank, Tsukuba, Japan), mouse myeloma SP2/O cells (CRL-1581), rat normal kidney cell line NRK-52E (CRL-1571) and human embryonic kidney cell line HEK293 (CRL-1573; American Type Culture Collection, Rockville, MD). These cells and the derived transfectant cells were maintained in DMEM supplemented with 10% FCS; the exception was SP2/O cells and derived hybridoma clones, which were maintained in RPMI-1640 supplemented with 10% FCS and 50 lM 2-mercaptoethanol.
LPS and antibodies
LPS from Escherichia coli ATCC 25922 was prepared as previously described (9) . FITC-conjugated LPS from E. coli O111:B4 was obtained from Sigma (St Louis, MO, USA). Rat anti-mouse TLR4/MD-2 mAb (MTS510) was prepared as previously described (4) . Mouse anti-mouse TLR4 mAbs (UT15 and UT41) were prepared as previously described (35) . UT41 was immobilized in Affi-Gel 10 (Bio-Rad, Hercules, CA, USA) according to the manufacturer's protocol. Rat anti-mouse CD14 mAbs M14-17 (IgG2a) and M14-23 (IgG2a) were established in our laboratory. Briefly, Wister rats (Charles River Japan, Yokohama, Japan) were immunized in the footpads with mCD14-expressing NRK-52E-transfectant cells (2 3 10 7 cells per head) emulsified in CFA at a total volume of 1.5 ml. One week later, cells were harvested from the draining lymph nodes of two immunized rats. The harvested cells were fused with SP2/O myeloma cells in polyethylene glycol 1500 using a standard fusion protocol. Following HAT selection, positive hybridoma clones were screened by immunofluorescence staining against HEK293-transfectant cells expressing mCD14, and single clones were isolated by limiting dilution. Purified antibodies were obtained from ascitic fluids of SCID mice by caprylic acid precipitation followed by ion exchange chromatography. Other antibodies were purchased from the following companies: mouse anti-FLAG M2 mAb (Sigma); rabbit anti-GFP antibody (Invitrogen, Carlsbad, CA, USA); mouse anti-LPS mAb WN1 222-5 (Hycult Biotechnology, PB Uden, The Netherlands); rabbit anti-TLR4 (Imgenex, San Diego, CA, USA); rabbit anti-GAPDH, anti-IjB-a, anti-phosphorylated IjB-a, anti-p38 mAbs and anti-phosphorylated p38 antibody (Cell Signaling Technology, Danvers, MA, USA); alkaline phosphatase (ALP)-conjugated goat anti-mouse IgG (American Qualex, San Clemente, CA, USA); ALPconjugated goat anti-rabbit IgG (Kirkegaard & Perry Laboratories, Gaithersburg, MD, USA) and PE-conjugated goat anti-rat IgG and PE-conjugated goat anti-mouse IgG (Southern Biotechnology Associates, Birmingham, AL, USA); PE-conjugated streptavidin (BD Biosciences, San Jose, CA, USA).
Preparation of anti-GFP antibody and immobilization on agarose gels
A cDNA fragment that coded for GFP was amplified from the pEGFP-N1 vector (Clontech, Mountain View, CA, USA) by PCR using a sense primer (5#-GGTGGATCCGATGGTGAG-CAAGGGCGA-3#) and an anti-sense primer (5#-AGAA-AGCTTTCACTATTACTTGTACAGCTCGTCC-3#). The fragment was subcloned into a pET32b vector (Novagen, Madison, WI, USA) at the BamHI and HindIII sites. The recombinant protein, which consisted of thioredoxin, His tag, thrombin cleavage sequence, S tag and GFP from the N-terminus, was expressed by the addition of isopropyl-b-D-thiogalactopyranoside in Origami B (DE3) (Novagen). Tag-free protein was prepared as previously described (36) . A JW/CSK rabbit (Japan SLC, Shizuoka, Japan) was intradermally immunized three times with 0.2 mg GFP in CFA and intravenously boosted three times with 50 lg GFP at 7-day intervals. An IgG fraction was prepared from the serum by ammonium sulfate precipitation and ion exchange chromatography using a DEAE-Sepharose column (GE Healthcare, Buckinghamshire, UK) and then immobilized on Affi-Gel 10.
Preparation of recombinant sCD14, full-length LBP and the truncated N-terminal form of lipopolysaccharide-binding protein
A cDNA fragment coding for the N-terminal 325 aa residues of mature human CD14 was amplified from an EST clone (BC010507) by PCR with a sense primer (5#-GAGGTCGA-CATCGATGAAGACTTATCGACCATGG-3#) and an anti-sense primer (5#-GCCGGATCCCATTGAGCCCTCGTGG-3#). cDNA fragments coding for human full-length LBP and the N-terminal 212 aa residues of LBP were amplified from an EST clone (BI762167) using a sense primer (5#-CGCCTCGA-GCACTGCACTGGGAATCTAGGATGG-3#) and anti-sense primers for LBP (5#-CGCAGATCTAACTCTCATGTATTGGA-CATTGGC-3#) and truncated N-terminal form of lipopolysaccharide-binding protein (LBP-N) (5#-GGCAGATCTCCGAGG-GGCTTCCACTAAGC-3#). Amplified cDNA fragments were subcloned into pCAGGS1, which was modified by introducing a FLAG tag and a 6-His tag at the C-terminus. CHO-DG44 cells were transfected with the expression constructs using a Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's protocol. Stable clones that produced high levels of recombinant protein were established by G418 selection following cultivation in the presence of methotrexate (200-600 nM). Established stable clones were cultured for 3 days in serum-free YMM medium (37) , and the supernatant was collected and filtered through a 0.45-lm sterile cellulose acetate membrane (Millipore, Billerica, MA, USA). sCD14 and LBP concentrations in the supernatants were determined using a Human sCD14 Quantikine enzymelinked immunosorbent assay kit (R&D Systems, Minneapolis, MN, USA) and a Human LBP enzyme-linked immunosorbent assay kit (Hycult Biotechnology), respectively. LBP-N concentration was estimated based on the density plot against full-length LBP, which was obtained by western blotting (WB) with anti-FLAG mAb.
Detection of TLR4 dimerization
TLR4 dimerization was detected as reported by Saitoh et al. (33) . Briefly, Ba/F3-transfectant cells expressing FLAGtagged MD-2 and two types of TLR4 tagged with either GFP (TLR4G) or FLAG (TLR4F) peptide at the C-terminus (gifts from Dr K. Miyake) were stimulated with LPS (1 lg ml À1 ) for 15 min; washed using serum-free medium and lysed in 20 mM Tris buffer, pH 7.5, 150 mM NaCl, 1 mM phenylmethylsulphonylfluoride (PMSF), 1% Brij35, 0.5% n-octyl-b-Dglucoside and 0.5% Triton X-100 for 30 min on ice. After centrifugation at 15 000 3 g for 15 min, the supernatants were incubated at 4°C for 2 h with anti-GFP antibodyimmobilized agarose. Gels were washed three times with 20 mM Tris buffer, pH 7.5, 150 mM NaCl, 1 mM PMSF, 0.1% Brij35, 0.1% n-octyl-b-D-gulcoside and 0.1% Triton X-100 and boiled in Laemmli buffer. Precipitated proteins were resolved on SDS-PAGE and electrophoretically blotted onto a polyvinylidene fluoride membrane. The blotted TLR4F and TLR4G were probed by a primary antibody of each specificity followed by ALP-conjugated secondary antibodies and visualization using a BCIP/NBT substrate (Promega, Madison, WI, USA).
Detection of LPS bound to TLR4/MD-2 on the cell surface LPS bound to TLR4/MD-2 was detected as previously reported (10) . Briefly, Ba/F3-transfectant cells (2 3 10 7 cells) were stimulated with LPS (1 lg ml À1 ) for 30 min; washed with serum-free medium and lysed in 20 mM Tris buffer (pH 7.5) containing 150 mM NaCl, 1 mM PMSF and 0.5% Triton X-100 for 30 min on ice. After centrifugation at 15 000 3 g for 15 min, the supernatants were incubated with anti-TLR4 mAb (UT41)-immobilized agarose gels at 4°C for 2 h. Gels were washed three times with 20 mM Tris buffer (pH 7.5) containing 150 mM NaCl, 1 mM PMSF and 0.1% Triton X-100 and boiled in Laemmli buffer. The precipitated materials were subjected to WB using anti-LPS mAb and anti-TLR4 antibody.
Flow cytometric analysis
Cells were stained at 4°C with a primary antibody in staining buffer (Ba/F3, HBSS containing 2% FCS and 0.1% azide; RAW264, PBS containing 3% FCS, 10 mM EDTA and 0.1% azide), washed three times with staining buffer and then incubated with a PE-conjugated secondary antibody or streptavidin. Flow cytometry analysis was performed on a FACScan (Becton Dickinson, Franklin Lakes, NJ, USA). For the detection of LPS on Ba/F3 cells, cells were incubated with FITC-conjugated LPS (20 lg ml À1 ) for 20 min, washed with staining buffer and then analyzed on a FACScan.
Detection of signaling molecules in LPS-stimulated cells
RAW264 cells (3 3 10
5 cells) were inoculated in a 24-well plate, cultured for 24 h and then transferred to 1 ml culture medium with or without FCS by washing three times with serum-free medium. Ba/F3-transfectant cells were washed three times with serum-free medium, and 1 3 10 7 cells were inoculated into a centrifugation tube with 1.5 ml culture medium. Where indicated, sCD14, LBP, LBP-N or anti-mouse CD14 mAbs was added to the culture. Cells were stimulated with 1 lg ml À1 LPS for the indicated period; washed with ice-cold PBS and lysed in 20 mM Tris buffer (pH 7.5) containing 150 mM NaCl, 1 mM EDTA, 1 mM PMSF and 1% Triton X-100 for 10 min on ice. Following centrifugation at 15 000 3 g for 15 min at 4°C, supernatants were subjected to WB using anti-GAPDH, anti-IjB-a, anti-phosphorylated IjB-a, anti-p38 or anti-phosphorylated p38 antibody followed by appropriate secondary antibodies and visualized as described above.
Results
LPS-induced TLR4/MD-2 dimerization requires mCD14 as an essential cellular component
To examine the molecular mechanisms underlying LPSinduced TLR4/MD-2 receptor dimerization, we used Ba/F3 cells transfected with TLR4F, TLR4G, MD-2 and mCD14 (32, 33) . Cells were stimulated with LPS in the presence of FCS for 15 min and lysed with detergents. Immunoprecipitation (IP) was performed using an anti-GFP antibody-immobilized gel, and coprecipitated TLR4F was detected by WB using an anti-FLAG mAb. As shown in Fig. 1(A) , anti-GFP antibody precipitated TLR4F in mCD14-positive TLR4/MD-2-transfectant cells (lane 8) when stimulated with LPS; however, this precipitation was not detectable in mCD14-negative cells (lane 2). This result indicates that LPS-induced dimerization of the TLR4/MD-2 receptor takes place only in mCD14-expressing cells. We observed another signal with faster mobility (indicated by asterisks in Fig. 1 ) in both anti-FLAG and anti-GFP WBs in all lanes. These signals were dependent on anti-FLAG or anti-GFP antibody and were specific to TLR4. We hypothesize that these signals represent endoglycosidase H-sensitive low molecular weight TLR4 that resides in the endoplasmic reticulum (38) (39) (40) and therefore does not participate in receptor dimerization on the cell surface during LPS stimulation.
The molecular requirements for TLR4/MD-2 dimerization were also assessed using anti-TLR4/MD-2 mAb MTS510 (4). This mAb reacted to surface TLR4/MD-2 on both Ba/F3-transfectant cells with mCD14 and a mouse macrophage cell line (RAW264) that expressed endogenous mCD14 (Fig. 1B) . However, the staining intensity decreased when cells were stimulated with LPS in the presence of FCS, a condition during which TLR4/MD-2 dimerization occurs (Fig. 1B,  lower histograms) . In contrast, reductions in staining intensity were not observed in mCD14-negative Ba/F3-transfectant cells stimulated with LPS. The staining intensity of anti-TLR4 mAb UT15 (35) did not change in response to LPS stimulation in these cells (Fig. 1B) . These results indicate that MTS510 mAb reactivity inversely correlates with the formation of TLR4/MD-2 clusters and may be a useful tool for detecting dimerization.
To examine whether dimerization occurs via the binding of LPS to mCD14, we produced a mAb (M14-23) that blocks this interaction. Pre-treatment of mCD14-positive-transfectant cells or RAW264 cells with M14-23 mAb blocked LPS binding as revealed by flow cytometry (Fig. 1C) . Another anti-CD14 mAb (M14-17) did not show these blocking effects. mCD14-positive-transfectant cells pre-treated with these mAbs were stimulated with LPS and then subjected to an IP-WB assay for detection of TLR4/MD-2 dimerization. As shown in Fig. 1(D) , M14-23 mAb, but not M14-17 mAb, blocked LPS-induced receptor dimerization. The blocking of dimer formation by M14-23 mAb was also confirmed by a flow cytometry using MTS510, a predictor mAb for dimer formation (Fig. 1E) . Thus, blocking of LPS binding to mCD14 by M14-23 mAb did not result in the reduction of MTS510 reactivity in LPS-stimulated mCD14-positivetransfectant cells and RAW264 cells. These results clearly indicate that mCD14 is required for LPS-induced receptor dimerization and that dimerization is initiated by the binding of LPS to mCD14.
LPS-induced TLR4/MD-2 dimerization requires LBP as an essential serum component
Despite the dimerization that occurs in LPS-stimulated mCD14-positive TLR4/MD-2-transfectant cells in the presence of FCS, coprecipitation of TLR4F was undetectable under serum-free conditions (Fig. 1A, lane 9) . This observation prompted us to identify serum molecules that mediate LPSinduced receptor dimerization. FCS contains various molecules, including bovine sCD14 and LBP, that contribute to LPS recognition. Therefore, we examined the effects of recombinant sCD14 and LBP prepared in CHO cells on LPS-induced dimerization in mCD14-positive-transfectant cells. Reconstitution of LBP restored LPS-induced dimerization to levels comparable to those seen in the presence of serum (Fig. 1A, lane 11) . The effect was dose dependent and peaked at 0.4 lg ml À1 ( Fig. 2A) . In contrast, reconstitution of sCD14 was ineffective for dimerization (Fig. 1A,  lane 10) . LBP-mediated dimerization was not affected by co-incubation with sCD14 (Fig. 1A, lane 12) . Similarly, we performed a reconstitution assay on mCD14-negative cells. Neither sCD14 nor LBP induced dimerization (Fig. 1A, remained ineffective (Fig. 1A, lane 6) . Consistent with these findings, MTS510 staining intensity decreased in LPSstimulated mCD14-positive cells with LBP but not sCD14 (data not shown).
To examine the role of LBP structure in TLR4/MD-2 dimerization, we prepared recombinant LBP-N, which lacks the C-terminal portion of LBP. LBP-N retains LPS-binding activity; however, the transferring activities of LPS to CD14 are impaired (16, 20) . LPS-induced receptor dimerization was markedly attenuated in the presence of LBP-N (Fig. 2B) . This may be because of the decreased transfer of LPS to mCD14 because only a small amount of LPS associated with TLR4/ MD-2 was detected in transfectant cells in the presence of LBP-N (Fig. 2B, bottom) . Taken together, these results indicate that LBP is an essential serum factor for LPSinduced receptor dimerization and that the collaboration between LBP and mCD14 is crucial in mediating receptor dimerization.
Dimerization is not necessary for TLR4/MD-2 signal transduction but is correlated with increased LPS binding of TLR4/MD-2
To determine whether dimerization is required for signal transduction via TLR4/MD-2 as proposed previously (32, 33) , we examined NF-jB activation in Ba/F3-transfectant cells after LPS stimulation. The same LPS concentrations and recombinant proteins used in the receptor dimerization experiments were used here. The cells were stimulated with LPS, and IjB-a levels in cytosolic fractions were determined by WB. In contrast to dimerization, stimulation of transfectant cells with LPS induced IjB-a degradation in mCD14-positive cells independent of the presence or absence of serum, LBP or sCD14 (Fig. 3A) . Moreover, mCD14-negative cells responded against LPS stimulation in the presence of sCD14 or serum (Fig. 3A) . The possibility for signal transduction via receptors other than TLR4/MD-2 may be ruled out because the LPS preparations used here did not stimulate activity in non-transfectant BaF3 cells (data not shown).
We further examined the amount of LPS bound to TLR4/ MD-2. Cells with and without mCD14 were stimulated with LPS and lysed in buffer containing detergent. Engagement of TLR4/MD-2 with LPS was determined by IP using an anti-TLR4 mAb-immobilized gel followed by WB with anti-LPS antibody. mCD14-positive cells stimulated with LPS in the presence of LBP or FCS showed significantly increased amounts of LPS binding to TLR4/MD-2 compared with cells stimulated either in serum-free medium or in the presence of sCD14 (Fig. 3B) . The increased amount of LPS binding completely disappeared after pre-incubation with anti-CD14 mAb M14-23, which blocks the binding of LPS to CD14. These effects were not observed in the control, which used anti-CD14 mAb M14-17 (Fig. 1D) . In addition, the amount of LPS that bound to TLR4/MD-2 decreased in cells stimulated in the presence of LBP-N (Fig. 2B) . In mCD14-negative cells, coprecipitation of LPS with TLR4/MD-2 was undetectable, even in the presence of sCD14, LBP or a combination of sCD14 and LBP (Fig. 3B) . These results indicate that receptor dimerization is correlated with the increased engagement of TLR4/MD-2 to LPS but is not necessary for receptor signaling.
TLR4 dimerization enables rapid signal transduction against LPS stimulation
To understand the functional significance of LPS-induced receptor dimerization, we examined the activation of signaling molecules in LPS-stimulated cells. In RAW264 cells stimulated by LPS in serum-free medium, IjB-a was phosphorylated at 15 min and degraded at 30 min. Phosphorylation of p38 was also detected at 30 min (Fig. 4A) . Stimulation with LPS in the presence of FCS resulted in rapid activation of signaling molecules. Thus, the kinetics of IjB-a degradation and IjB-a and p38 phosphorylation were shifted to an early phase compared with serum-free stimulation. Such earlyphase activation in IjB-a and p38 by LPS stimulation was also observed in the presence of LBP (Fig. 4A) . In contrast, the shift to early-phase activation was not observed in LPSstimulated RAW264 cells in the presence of sCD14 (Fig. 4A) .
We also examined the effects of anti-CD14 mAb M14-23, which blocks receptor dimerization, on LBP-mediated early activation of IjB-a and p38. RAW264 cells were pre-treated with M14-23 mAb and stimulated with LPS in the presence of LBP. Rapid activation of signaling molecules was inhibited by M14-23 mAb but not by anti-CD14 mAb, M14-17 (Fig. 4B) . In addition, we discovered that signaling kinetics were not altered by LBP-N (Fig. 4C) . Taken together, these results demonstrate that LPS-induced receptor dimerization accelerates signal transduction and that receptor dimerization enables rapid signaling.
Discussion
Using Ba/F3 cells transfected with FLAG-and GFP-tagged TLR4 molecules, and through a combination of IP and WB assays (32, 33) , we demonstrated that mCD14 is essential for LPS-induced dimerization of TLR4/MD-2 receptors. Receptor dimerization occurred only in the presence of serum, and LBP was an essential component. Specifically, the addition of recombinant LBP obtained from CHO-DG44-transfectant cells led to LPS-induced dimerization in serumfree culture.
We found that receptor dimerization can also be assessed using the anti-TLR4 mAb MTS510 (4). This mAb can detect conformational changes in LPS-stimulated TLR4 molecules ). After stimulation for the indicated period, cell lysates were prepared and analyzed using WB with the indicated antibodies.
Rapid TLR4 signaling via dimerization 277 that may be correlated with receptor activation (32, 34) . We observed that MTS510 reactivity inversely correlates with receptor dimerization but not receptor signaling. Thus, when LPS-induced TLR4/MD-2 dimerization occurred in mCD14-positive Ba/F3 cells, MTS510 reactivity against TLR4 was lost (Fig. 1B) . Regardless of LPS-induced signaling, MTS510 maintained antigen reactivity in mCD14-negative cells (Fig. 1B and 3A) . RAW264 cell lines and peritoneal macrophages lost reactivity against MTS510 after LPS stimulation (data not shown), indicating that transfectant cell lines and physiological cells show TLR4/MD-2 receptor dimerization when stimulated with LPS.
The binding of LPS to mCD14 appears to be critical for receptor dimerization; the addition of anti-CD14 mAb M14-23, which blocks the binding of LPS to CD14, almost completely prevented LPS-induced receptor dimerization in TLR4/MD-2/ mCD14-expressing Ba/F3 cells (Fig. 1C and D) . There was no effect of anti-CD14 mAb (M14-17), which does not block LPS binding.
We demonstrated that LBP, a serum component that extracts LPS from Gram-negative bacterial cell surfaces and transfers it to CD14 (11) , is essential for LPS-induced dimerization. The importance of LPS transfer from LBP to mCD14 for receptor dimerization was demonstrated using truncated LBP containing N-terminal 212 aa residues (LBP-N) that reserve the ability to bind LPS but have lost the ability to transfer LPS to CD14 (16, 20) . Receptor dimerization was severely impaired in the presence of LBP-N in TLR4/MD-2/ mCD14-expressing Ba/F3 cells because of the reduced transfer of LPS to mCD14. The unexpected weak dimerization signal and the small amounts of LPS bound to transfectant cells (Fig. 2B ) may be due to the incomplete loss of transfer activity of the recombinant LBP-N preparation, which was 15 aa residues longer than that reported by others (16, 20) . Surprisingly, although mCD14 was essential for LPSinduced receptor dimerization, sCD14 did not compensate for mCD14. Several reports have demonstrated functional differences between mCD14 and sCD14. mCD14, but not sCD14, promotes the phagocytosis of Gram-negative bacteria by monocytes, and this effect is blocked by sCD14 (41, 42) . Monocytes take up LPS predominantly by a mCD14-dependent mechanism, whereas mCD14-negative cells, such as endothelial cells and epithelial cells, slowly take up LPS via scavenger receptors (43) . LPS uptake and receptor dimerization is accompanied by TLR4/MD-2 endocytosis in mCD14-positive cells (32) . Taking these observations together with the rapid signal transduction as we discuss below, it is tempting to speculate that receptor dimerization may be critically involved in phagocytosis. For the phagosome maturation, it is clearly demonstrated that MyD88-dependent signal is required to be emanated from phagocytic cargo containing pathogenic microorganism (44) . A MyD88-p38 signal is also reported to induce phagocytic gene program including scavenger receptor genes in macrophages (45) . The increased engagement of LPS to TLR4/MD-2 accompanied by LPS-induced receptor dimerizaton in the presence of mCD14 and LBP (Fig. 3) may enhance the phagocytic activities through increased MyD88-p38 signal transduction. The rapid signal transduction by the formation of receptor dimerization may further enhance the phagocytosis. Alternatively, but not mutually exclusive, receptor dimerization per se might enhance phagocytosis by unknown mechanisms. Collectively, mCD14 together with LBP may provide an efficient way by which TLR4/MD-2 engages in LPS during phagocytosis, resulting in the rapid signaling to eliminate bacteria and induce adaptive immunity.
Because it is well correlated with LPS activities, the dimerization of TLR4/MD-2, which was detected using IP-WB assay in the present study, is considered to be strictly required for LPS signaling (9, 32, 33) . However, our present results indicate that this is not necessarily the case. Despite the absence of dimerization, TLR4/MD-2-transfected Ba/F3 cells without mCD14 showed IjB-a degradation after LPS stimulation (Fig. 3) . mCD14-positive TLR4/MD-2-transfected Ba/F3 cells stimulated with LPS in the absence of FCS or LBP also showed IjB-a degradation. LPS stimulation of RAW264 cells in the absence of serum, where receptor dimerization did not occur, showed degradation of IjB-a and phosphorylation of p38 (Fig. 4) . These results indicate that TLR4/MD-2 dimerization is not required for signaling to occur. One previous study observed that expression of a chimeric construct composed of integrin av or b5/TLR4 on 293T cells induces constitutive NF-jB activation (25) , which supports our findings that the TLR4 monomer is able to transduce activation signals. It is difficult to completely dismiss the possibility that LPS stimulation induces a small number of TLR4 dimer molecules on mCD14-negative cells because these measurements are beyond our detection sensitivity, however, that likely does not occur because the staining patterns and intensity of conformation-dependent MTS510 staining of LPS-stimulated mCD14-negative cells are similar irrespective of the presence or absence of LPS.
Rather than acting as an absolute requirement for signaling, we suggest that LPS-induced dimerization of TLR4/ MD-2 receptors contributes to the rapid response against LPS. RAW264 cells stimulated with LPS in the presence of FCS or LBP showed earlier IjB-a phosphorylation and degradation compared with LPS stimulation in the absence of serum (Fig. 4) . In addition, p38 MAPK showed earlier phosphorylation in the presence of FCS or LBP. The earlier activation of signaling molecules was blocked by preventing LPS from binding to mCD14 using anti-CD14 mAb (M14-23). Furthermore, early activation was undetectable following the addition of LBP-N in culture. The introduction of mCD14 to mCD14-negative cells (12) and the addition of LBP to culture (12, 16, 17) enhance LPS sensitivity and augment LPSinduced immune responses because of increased LPS binding and transfer to TLR4/MD-2 by mCD14/LBP. Taken together, we propose that TLR4/MD-2 dimerization promoted by mCD14 and LBP contributes to increased sensitivity in LPS-induced innate immunity.
TLR4 activates two distinct signaling pathways controlled by MyD88/TIR domain-containing adapter protein and TRIF/ TRIF-related adapter molecule adapter pairs (2) . It was proposed that TLR4 at first activates MyD88 pathway at plasma membrane, is endocytosed and then sequentially initiates TRIF pathway from early endosomal compartment (46) . It has been believed that MyD88 pathway involves in early activation of NF-jB and MAPK (2) . In contrast, TRIF pathway involves in the late activation in addition to the activation of IFN regulatory factor-3 linking to IFN-b production. At least 3-min stimulation was shown to be sufficient to detect dimerized TLR4 (33) . Our current study also detected cell surface receptor dimerization by flow cytometry using MTS510 mAb as early as 5 min after stimulation (data not shown). Therefore, the dimerization may associate with MyD88 pathway rather than TRIF pathway. In fact, we were not able to show prominent phosphorylation of IFN regulatory factor-3 at an earlier time after stimulation in the presence of FCS (data not shown). Along with the importance in phagocytosis, further investigation is required to understand how TLR4 signal pathway is modulated by LBP and mCD14 via the dimer formation.
We hope that this study sheds new light on the functional link between TLR4/MD-2 and the accessory molecules mCD14 and LBP. 
